Back to Search
Start Over
BioCanRx Summit for Cancer Immunotherapy 2022 Proceedings.
- Source :
- Biochemistry & Cell Biology; 2024, Vol. 102 Issue 1, p1-8, 8p
- Publication Year :
- 2024
-
Abstract
- From 19 to 21 November 2022, BioCanRx held its first post-pandemic in-person Summit for Cancer Immunotherapy in Montreal, Canada. The meeting was well attended by patients, trainees, researchers, clinicians, and industry professionals, who came together to discuss the current state and future of biotherapeutics for cancer in Canada and beyond. Three plenaries, three keynote speakers, a lively debate, and panel discussions, together with poster sessions and a social event, made the event memorable and productive. The current state of cellular therapies, cellular engineering, clinical trials, and the role of the cancer microbiome were discussed in plenary session, and the patient voice was welcomed and present throughout the meeting, in large part due to the Learning Institute, a BioCanRx initiative to include patient partners in research. In this meeting review, we highlight the platform presentations, keynote speakers, debate combatants, panellists, and the patient perspective on the annual meeting. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 08298211
- Volume :
- 102
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Biochemistry & Cell Biology
- Publication Type :
- Academic Journal
- Accession number :
- 175162693
- Full Text :
- https://doi.org/10.1139/bcb-2023-0207